🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis

Recruitingn/aAges 18 Years - 80 YearsAllFirst Affiliated Hospital of Wannan Medical Colle…
NCT07022847 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

What is this study about? We are studying whether the Pleth Variability Index (PVI)-a simple, non-invasive measurement from a pulse oximeter-can help predict low blood pressure (hypotension) during routine maintenance hemodialysis. Low blood pressure during dialysis is a common and potentially serious complication. Our goal is to find out if monitoring PVI can help identify patients at risk, so that early action can be taken. Who can join? Adults aged 18 to 80 years. Patients who have been receiving maintenance hemodialysis regularly for more than 3 months. Those who are willing and able to participate and sign an informed consent form. Who cannot join? Patients with severe heart rhythm problems, severe peripheral circulation problems, or swelling that makes PVI measurement unreliable. Patients who are pregnant or breastfeeding. Patients allergic to the dialysis filter or unable to c

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 to 80 years. * Diagnosis of end-stage renal disease and undergoing maintenance hemodialysis for more than 3 months. * Able and willing to provide informed consent and comply with study procedures. Exclusion Criteria: * Severe cardiac arrhythmias or significant peripheral vascular disease that may interfere with PVI measurements. * Local edema, skin lesions, or other conditions that prevent accurate PVI monitoring. * History of hemodynamic instability unrelated to dialysis. * Pregnant or breastfeeding women. * Known allergy or contraindication to materials used in the hemodialysis circuit. * Unable to cooperate with study procedures. * Participation in another interventional clinical study within the past 30 days.
💊

What it tests

  • Non-invasive Monitoring
📍

Where

1 site
The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
Wuhu, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy